Abstract: A 64‐year‐old woman, who had presented with a 30‐year history of refractory asthma, and been treated with anti‐allergic drug therapy, inhaled corticosteroids, a long‐acting beta‐agonist, and a long‐acting muscarinic antagonist. She had been characterized as an allergic, eosinophilic asthmatic. Although omalizumab was tried initially, it was found to be insufficient. We began treatment with benralizumab. The asthma symptom control and sinusitis were improved immediately. Benralizumab was effective for overlapping patient population following negative initial results with omalizumab.
Effectiveness of benralizumab for allergic and eosinophilic predominant asthma following negative initial results with omalizumab
- Details
- Published on Monday, 03 December 2018 21:51
- Written by Juan Carlos Ivancevich

Case Report - Open Access
Interasma on Twitter
Interasma
Interasma - CME:Unlocking the Door to Asthma Control: Key Factors for Therapy Selection and Medication Management https://t.co/CiCJQvIgF9
Interasma
RT @worldallergy: Top story: This Is Why Food Allergies Are on the Rise, According to Experts https://t.co/oySQs4f4jq, see more https://t.c…
Interasma
RT @worldallergy: WAO Tweeted Times https://t.co/1tA4uy3LDq - top stories by @ARIAGuideline, @Interasma